POLA2
Basic information
Region (hg38): 11:65261913-65305959
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Telomere Biology Disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POLA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 42 | 44 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 1 | 42 | 1 | 0 |
Variants in POLA2
This is a list of pathogenic ClinVar variants found in the POLA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-65262306-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
11-65262325-G-C | not specified | Uncertain significance (Oct 05, 2022) | ||
11-65262369-A-G | not specified | Uncertain significance (Sep 16, 2021) | ||
11-65266642-C-G | not specified | Uncertain significance (Jan 19, 2024) | ||
11-65266646-C-G | not specified | Uncertain significance (Dec 07, 2023) | ||
11-65266691-C-G | not specified | Uncertain significance (Oct 05, 2023) | ||
11-65267483-A-G | not specified | Uncertain significance (Dec 02, 2022) | ||
11-65267496-C-T | not specified | Uncertain significance (May 29, 2024) | ||
11-65267517-G-T | not specified | Uncertain significance (May 07, 2024) | ||
11-65267559-T-C | Telomere Biology Disorder | Likely pathogenic (Jan 09, 2024) | ||
11-65268676-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
11-65275952-A-G | not specified | Likely benign (Sep 27, 2024) | ||
11-65275965-A-G | not specified | Uncertain significance (Sep 30, 2021) | ||
11-65278768-G-A | not specified | Uncertain significance (Nov 09, 2024) | ||
11-65279552-A-G | not specified | Uncertain significance (Aug 05, 2024) | ||
11-65281010-G-A | not specified | Uncertain significance (Nov 03, 2023) | ||
11-65281017-T-C | not specified | Uncertain significance (Dec 20, 2023) | ||
11-65281064-G-A | not specified | Uncertain significance (May 11, 2022) | ||
11-65281086-C-T | not specified | Uncertain significance (Jan 10, 2023) | ||
11-65281115-G-A | not specified | Uncertain significance (Jun 26, 2024) | ||
11-65281676-A-T | not specified | Uncertain significance (Oct 09, 2024) | ||
11-65282482-G-A | not specified | Uncertain significance (Nov 12, 2024) | ||
11-65287760-A-G | not specified | Uncertain significance (Feb 22, 2023) | ||
11-65289065-G-C | not specified | Uncertain significance (May 05, 2023) | ||
11-65289068-G-A | not specified | Uncertain significance (Feb 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
POLA2 | protein_coding | protein_coding | ENST00000265465 | 18 | 43828 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.73e-7 | 1.00 | 125702 | 0 | 46 | 125748 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.06 | 278 | 332 | 0.837 | 0.0000176 | 3857 |
Missense in Polyphen | 78 | 100.24 | 0.77812 | 1138 | ||
Synonymous | 0.189 | 137 | 140 | 0.980 | 0.00000857 | 1206 |
Loss of Function | 3.29 | 17 | 39.2 | 0.434 | 0.00000225 | 421 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000269 | 0.000269 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000240 | 0.000237 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000264 | 0.000261 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play an essential role at the early stage of chromosomal DNA replication by coupling the polymerase alpha/primase complex to the cellular replication machinery. {ECO:0000250}.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);DNA replication - Homo sapiens (human);Purine metabolism - Homo sapiens (human);miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Pyrimidine metabolism;G1 to S cell cycle control;DNA Replication;Inhibition of replication initiation of damaged DNA by RB1/E2F1;Polymerase switching on the C-strand of the telomere;Purine metabolism;Activation of the pre-replicative complex;E2F mediated regulation of DNA replication;Mitotic G1-G1/S phases;DNA replication initiation;DNA Replication;Pyrimidine metabolism;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Telomere C-strand synthesis initiation;Telomere C-strand (Lagging Strand) Synthesis;Extension of Telomeres;Telomere Maintenance;Chromosome Maintenance;G1/S Transition;DNA Replication Pre-Initiation;M/G1 Transition;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.269
Intolerance Scores
- loftool
- 0.705
- rvis_EVS
- -0.78
- rvis_percentile_EVS
- 12.97
Haploinsufficiency Scores
- pHI
- 0.517
- hipred
- Y
- hipred_score
- 0.634
- ghis
- 0.685
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.999
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pola2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- G1/S transition of mitotic cell cycle;DNA replication;DNA replication initiation;telomere maintenance via semi-conservative replication;DNA biosynthetic process
- Cellular component
- nucleoplasm;alpha DNA polymerase:primase complex;cytosol
- Molecular function
- molecular_function;DNA binding;DNA-directed DNA polymerase activity;protein heterodimerization activity